1. Home
  2. LTRN vs ARAY Comparison

LTRN vs ARAY Comparison

Compare LTRN & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

HOLD

Current Price

$2.82

Market Cap

46.8M

Sector

Health Care

ML Signal

HOLD

Logo Accuray Incorporated

ARAY

Accuray Incorporated

HOLD

Current Price

$0.23

Market Cap

39.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LTRN
ARAY
Founded
2013
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.8M
39.3M
IPO Year
2020
2006

Fundamental Metrics

Financial Performance
Metric
LTRN
ARAY
Price
$2.82
$0.23
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$3.50
AVG Volume (30 Days)
151.2K
1.2M
Earning Date
05-14-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
18.65
87.50
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.58
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.11
$0.23
52 Week High
$5.74
$2.10

Technical Indicators

Market Signals
Indicator
LTRN
ARAY
Relative Strength Index (RSI) 38.32 34.69
Support Level $2.49 N/A
Resistance Level $3.79 $0.29
Average True Range (ATR) 0.27 0.02
MACD -0.06 0.00
Stochastic Oscillator 9.91 8.09

Price Performance

Historical Comparison
LTRN
ARAY

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

About ARAY Accuray Incorporated

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.

Share on Social Networks: